US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist

31.560
-2.200-6.52%

Close Mar 26 16:00 ET

32.160
+0.600+1.90%

Post 16:28 ET

13.68BMarket Cap16.52P/E (TTM)

Royalty Pharma Stock Forum

Teddy123

Feb 11 20:24

Royalty Pharma Reports Q4 and Full Year 2024 Results

$Royalty Pharma (RPRX.US)$
Royalty Pharma's Triple Win: 12% Revenue Jump, Massive Buyback, and Strategic Acquisition

donatello

Jan 13 22:31

😬

$Royalty Pharma (RPRX.US)$

donatello

Jan 10 21:44

let's gooo

$Royalty Pharma (RPRX.US)$

donatello

Dec 24, 2024 01:01

🤔

$Royalty Pharma (RPRX.US)$

Trytosaveabit

Nov 5, 2024 05:05

News

$Syndax Pharmaceuticals (SNDX.US)$ $Royalty Pharma (RPRX.US)$ Press Release: Syndax Pharmaceuticals and Royalty Pharma Enter Into $350 Million Royalty Funding Agreement for Niktimvo(TM)
Dow Jones· 1 min ago

Moomoo AI

Feb 22, 2024 18:36

Unusual items boosting Royalty Pharma's profit may not recur, possibly causing a profit drop this year. The company's statutory earnings may not truly reflect its underlying earnings power. Investors should note 4 warning signs for Royalty Pharma.

There May Be Underlying Issues With The Quality Of Royalty Pharma's (NASDAQ:RPRX) Earnings

Moomoo AI

Dec 18, 2023 19:24

Significant insider share selling might worry some shareholders despite the implication of the company acting in all shareholders' interest. The overall analysis of insider transactions, however, lacks confidence.